Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arrowhead Pharmaceuticals (ARWR) Interest Coverage Ratio (2022 - 2025)

Arrowhead Pharmaceuticals' Interest Coverage Ratio history spans 4 years, with the latest figure at 1.81 for Q4 2025.

  • For Q4 2025, Interest Coverage Ratio rose 124.32% year-over-year to 1.81; the TTM value through Dec 2025 reached 3.33, up 125.88%, while the annual FY2025 figure was 1.1, 105.92% up from the prior year.
  • Interest Coverage Ratio reached 1.81 in Q4 2025 per ARWR's latest filing, down from 2.03 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 17.62 in Q1 2025 to a low of 34.58 in Q2 2024.
  • Average Interest Coverage Ratio over 4 years is 9.77, with a median of 11.07 recorded in 2024.
  • Peak YoY movement for Interest Coverage Ratio: plummeted 282.9% in 2024, then surged 201.13% in 2025.
  • A 4-year view of Interest Coverage Ratio shows it stood at 14.79 in 2022, then tumbled by 72.03% to 25.44 in 2023, then skyrocketed by 70.69% to 7.46 in 2024, then skyrocketed by 124.32% to 1.81 in 2025.
  • Per Business Quant, the three most recent readings for ARWR's Interest Coverage Ratio are 1.81 (Q4 2025), 2.03 (Q3 2025), and 6.79 (Q2 2025).